{"ticker": {"uuid": "faf43de1-aad0-4aa0-98eb-93c011d3d249", "symbol": "JNJ", "name": "Johnson & Johnson", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "Goldman Sachs Adjusts Price Target on Johnson & Johnson to $282 From $275, Maintains Buy Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/goldman-sachs-adjusts-price-target-103732675.html", "source_name": "MT Newswires", "published_at": "2026-07-16T10:37:32+00:00", "published_display": "16 Jul 2026 10:37", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stifel Adjusts Price Target on Johnson & Johnson to $260 From $250, Maintains Hold Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/stifel-adjusts-price-target-johnson-095609531.html", "source_name": "MT Newswires", "published_at": "2026-07-16T09:56:09+00:00", "published_display": "16 Jul 2026 09:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scotiabank Adjusts PT on Johnson & Johnson to $305 From $265, Maintains Sector Outperform Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/scotiabank-adjusts-pt-johnson-johnson-095603813.html", "source_name": "MT Newswires", "published_at": "2026-07-16T09:56:03+00:00", "published_display": "16 Jul 2026 09:56", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Raymond James Adjusts PT on Johnson & Johnson to $265 From $258, Maintains Outperform Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/raymond-james-adjusts-pt-johnson-095554576.html", "source_name": "MT Newswires", "published_at": "2026-07-16T09:55:54+00:00", "published_display": "16 Jul 2026 09:55", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Morgan Stanley Adjusts PT on Johnson & Johnson to $294 From $284, Maintains Overweight Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/morgan-stanley-adjusts-pt-johnson-095541168.html", "source_name": "MT Newswires", "published_at": "2026-07-16T09:55:41+00:00", "published_display": "16 Jul 2026 09:55", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "JPMorgan Adjusts Price Target on Johnson & Johnson to $270 From $260, Maintains Neutral Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/jpmorgan-adjusts-price-target-johnson-095529516.html", "source_name": "MT Newswires", "published_at": "2026-07-16T09:55:29+00:00", "published_display": "16 Jul 2026 09:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wells Fargo Adjusts Price Target on Johnson & Johnson to $272 From $263, Maintains Overweight Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/wells-fargo-adjusts-price-target-095523264.html", "source_name": "MT Newswires", "published_at": "2026-07-16T09:55:23+00:00", "published_display": "16 Jul 2026 09:55", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Leerink Partners Adjusts PT on Johnson & Johnson to $276 From $265, Maintains Outperform Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/leerink-partners-adjusts-pt-johnson-095515809.html", "source_name": "MT Newswires", "published_at": "2026-07-16T09:55:15+00:00", "published_display": "16 Jul 2026 09:55", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Principal Financial Group Inc. Sells 38,576 Shares of Johnson & Johnson $JNJ", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxPMVRTajFqYUxON3dENnBUZWZjeTFDaGVqUEJqYVc0VlBweVhsY1hVQV9DX3JBR2ZZa3BfVzJlQ2lWZ1BibDZucVFuY2ZONkI0X2NBZk5CczNBanVKalQ5QW1YcC1GOUVZNWJsTlM2VFh6cTl6c0FmNlBncC0wRmdvRXNpOHlycXl0cUo0VERBal9jeDFYX09fVnJQcDhlcDZrdk42ZjkyY2ZmOEwyRHdmbjRGX3JsYUVjNTQ2dGZpdU9VMS1EeGV6YWh5bGE?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-16T09:05:52+00:00", "published_display": "16 Jul 2026 09:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson $JNJ Shares Acquired by TFR Capital LLC.", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNR3dVMEk4cVI3X3A0ang2bnVGYk9ic1JYWG96MEN2R1YxaFFiQWV1QXNIWS13ck5fWTBhT2lLT1lHYzV5TVk3Zm5NOEdQUTRrLXlpQW5fN19BZXRzeUNNYXVXaF9OM0wwek1hQ0YyZU9wMFFJSWFVMjlaSVlwZWw4TUFfTmVJSkVYYWZsREhjeEpvaDdqMmpUSEY2a0t3RjZoMHpOZFhqalYwT1JGWEVVMkg0ZHNCZw?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-16T09:03:59+00:00", "published_display": "16 Jul 2026 09:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Calamos Wealth Management LLC Sells 6,096 Shares of Johnson & Johnson $JNJ", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxOWHdhdDB5bWxJYWpyWUFObXVCcmQ4ZVhPNTZPNXQtQ1hIdldMOW9SUkxQR3JDcm10STRPeVFKRGtFRGZaX1R4a25aNlZ1V09PaE0wbmNtVmNSQUN4ZVg2a0RZcF95aFBLUDJJTVlGYXRjdWljQnA2Z2V2VHNuWW52UC1vV0g5YUdZRTZjSUtHNWZOUEZtYnJWX1FNSENXSmtOQzdtNjRCOURleE5WNTNYQ1FfMk5DYXZVN3FBLUhTTk5BWmpQYnlLVDdKQQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-16T08:07:37+00:00", "published_display": "16 Jul 2026 08:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Calamos Advisors LLC Purchases 122,350 Shares of Johnson & Johnson $JNJ", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQMXZHOVB5QTN4alZVRFJSem9HLWZPeGJaTHhMSlJrR2xONEtFSDVNaWNpdm5DcE50eElaLXZCY1hYZlVOR21DR1dnNndISEZ0MXBUNWQ5RDhqUUpQX1RnNzNQV1FCRTlFSUNPUHlFc19NcEM2b1FfWEZQYVBDSG9XcUdncXE2X1lIcVJOUTZ5VGVhOXloajZSMGdwUFZlOXZHUi14WHdJU2RpZXg1QmJUeklNMkI3NS1mbEpkWkExSEo3RVVVWE9j?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-16T07:43:32+00:00", "published_display": "16 Jul 2026 07:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Birinyi Associates Inc. Invests $4.16 Million in Johnson & Johnson $JNJ", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPaWE0VjFjbmRoejBJbnpBdmI0RXVZVkpZZ0NnQnMxR3lTSV9XMUktSlcyMFpJZTBKa1ZBeC1TMnJpTjlyZXVfSTZrVmI2dmhUTzduLUt5WkRMTnBLZmRIalFaWjR6aVNMV0haN3lnSl92VUxXVU5JMkZCWjlmVHZTVU8za3J0UXBObEJWR3l6VHRFLW9IWjU3TEF0dk90WTNQMzUzTWhBdEs3TmprUUtUT0tCTmVGa1F6MnZkLUg3Ti16WjhG?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-16T07:43:32+00:00", "published_display": "16 Jul 2026 07:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ghe LLC Has $138,000 Stock Holdings in Johnson & Johnson $JNJ", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNOFNjNXJpUmpQcGpvSlBacVlEMjZfQjg4RUQ0SU55a0taSGxKVVlZZm9YSjVUNnh3cjZpTU5UZy1XblVFVkhsNlZfdjU4VmdpWGRFYVYwWTlFb29sTkVWNG90MTBwUW9Gbk9yVVpRUlc3UG9yMS1vRXBpYjdHTVZoYXcxTWRjdnNMZUZGYnMycTB2cXZwdE80Z1Yxb3phVVlOcW5fXzNHRDR0dDN2N1ZQXy1UWTlMbXNo?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-16T07:43:31+00:00", "published_display": "16 Jul 2026 07:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bleakley Financial Group LLC Boosts Holdings in Johnson & Johnson $JNJ", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxNLW5jN2p2VmhHWEhBOG1hbV9ldWtMaEYzalVTWUJqT0N6aS1KQnFBZ0c2aUpIT0NBVjZNUVA4Zl91bmRNd1kwc3NoeVZhSVcxTGlSS3lybUx4YmFocEJpV2NWT28yRm9UdndYd1NOTXY3Y3hsZkFrNC13a2N6b29RU0c5NnV3b0lhNzh4RGNtNUdvYmpHMmdmSmNrc3I5NjFNcmtBaHhXVUl1UW5INGVuMEh2eVBCdHhRcnplaFcwS3JMUHhwcmpr?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-16T07:25:31+00:00", "published_display": "16 Jul 2026 07:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson $JNJ Shares Purchased by AMG National Trust Bank", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPU1JGa2x4SlhsaWZYZi1TdnhEZ0E4X3lIQ25DVGdzSUdIaDRxVm5RdWpseC1OcnJsaG5DZnNudGlpbFlaNTduNnhRaGtFR19WZW5HM0hDNHd2WWw5MTMwTDB2TWFTU3V0dHBUQ0VkUDFoQjJvUTZTTlk2VzFYNjZLQUJFSE9VbThLem9nX0RrOXF4c0pBVkt3anlXaHMzU2REeUdQNkItUlFic0owU0xsTTBpZUFRRHpQX0M4QzliRzVmQQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-16T07:08:36+00:00", "published_display": "16 Jul 2026 07:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson commits to $55B, 4-year US investment plan", "summary": "Johnson & Johnson's CFO Joe Wolk announced the company's commitment to a $55 billion, four-year investment plan in the US. Wolk discussed this plan, along with the company's Q2 earnings and the performance of its medical technology unit, including Impella heart pumps, during an i", "url": "https://www.foxbusiness.com/video/6401230115112", "source_name": "Fox Business", "published_at": "2026-07-15T20:07:05", "published_display": "15 Jul 2026 20:07", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson Earnings: Steady Growth and Good Near-Term Visibility", "summary": "Johnson & Johnson reported a 6.6% revenue growth in the second quarter, driven by strong performances in Innovative Medicine and MedTech, leading management to increase 2026 guidance. While shares dropped 2% intraday, Morningstar is maintaining its $190 fair value estimate, notin", "url": "https://www.morningstar.com/stocks/johnson-johnson-earnings-steady-growth-good-near-term-visibility", "source_name": "Morningstar", "published_at": "2026-07-15T19:15:57", "published_display": "15 Jul 2026 19:15", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson CFO Says Guidance Hike Is Just the Start", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxOMTZYX0hFVUhHanBBV2p1TmxlaTRIOHYybmNSZzhoUnl2c2RVRkJrdU01MEtqc00xM205TmRYNEllSFp5Tmd1cXBfWEV4RG5WWkRULV8xZFBWck9LT0dVX1VySnpheE5uRlpFUzZDZHhmZm8wRW5sNFBnYjJrelFCaEpLTTdDOWFOZ0E?oc=5", "source_name": "Barron's", "published_at": "2026-07-15T18:13:00+00:00", "published_display": "15 Jul 2026 18:13", "sentiment": "positive", "sentiment_pct": 58, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amid $55B US manufacturing push, J&J turns to streamlining its pharma supply chain", "summary": "Johnson & Johnson is restructuring its pharmaceutical supply chain, announcing up to $750 million in costs to streamline operations, including offloading certain sites. This move follows a $55 billion commitment to bolster U.S. manufacturing capabilities for medicines in the U.S.", "url": "https://www.biospace.com/business/amid-55b-us-manufacturing-push-j-j-turns-to-streamlining-its-pharma-supply-chain", "source_name": "BioSpace", "published_at": "2026-07-15T17:56:57", "published_display": "15 Jul 2026 17:56", "sentiment": "positive", "sentiment_pct": 67, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2026", "summary": "Johnson & Johnson (NYSE: JNJ) has declared a cash dividend of $1.34 per share for the third quarter of 2026. This dividend will be payable on September 8, 2026, to shareholders recorded by August 25, 2026. The ex-dividend date is also set for August 25, 2026.", "url": "https://www.biospace.com/press-releases/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2026", "source_name": "BioSpace", "published_at": "2026-07-15T17:08:44", "published_display": "15 Jul 2026 17:08", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson\u2019s Spravato sales growth supports psychedelic drug opportunity: Jefferies", "summary": "Jefferies notes that strong Q2 sales of Johnson & Johnson's Spravato, a depression treatment, indicate a promising long-term commercial opportunity for psychedelic drugs in treating mental health disorders. The drug's annual revenue run rate of over $2.3 billion and its potential", "url": "https://www.proactiveinvestors.com/companies/news/1095518/johnson-johnson-s-spravato-sales-growth-supports-psychedelic-drug-opportunity-jefferies-1095518.html", "source_name": "Proactive financial news", "published_at": "2026-07-15T15:34:04", "published_display": "15 Jul 2026 15:34", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "No patent protection for Stelara? No problem for J&J as Tremfya fills the void", "summary": "Johnson & Johnson has increased its annual sales guidance after a strong second quarter, largely driven by the performance of its immunology portfolio. Despite a significant drop in Stelara sales due to patent expiry, the company's new drug Tremfya largely compensated for the dec", "url": "https://www.fiercepharma.com/pharma/no-patent-protection-stelara-no-problem-jj-tremfya-fills-void", "source_name": "Fierce Pharma", "published_at": "2026-07-15T15:30:49", "published_display": "15 Jul 2026 15:30", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "J&J raises FY26 outlook following positive Q2", "summary": "Johnson & Johnson (J&J) reported strong Q2 revenues of $25.3 billion, a 6.6% year-over-year increase, primarily driven by its Innovative Medicine business and J&J MedTech. Following these results, the company raised its 2026 earnings outlook to $11.60-$11.75 per share. Despite th", "url": "https://finance.yahoo.com/healthcare/articles/j-j-raises-fy26-outlook-151414239.html", "source_name": "Market source", "published_at": "2026-07-15T15:13:49", "published_display": "15 Jul 2026 15:13", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "J&J axes eye disease gene therapy after key phase 2b readout", "summary": "Johnson & Johnson has discontinued the development of JNJ-1887, an eye disease gene therapy for geographic atrophy, after reviewing topline data from its phase 2b Parasol study. The company had acquired the asset in 2020 and initiated the 305-subject trial in 2023, aiming to slow", "url": "https://www.fiercebiotech.com/biotech/jj-axes-eye-disease-gene-therapy-after-key-phase-2b-readout", "source_name": "Fierce Biotech", "published_at": "2026-07-15T14:38:50", "published_display": "15 Jul 2026 14:38", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What's Going on With Johnson & Johnson Stock Wednesday? - Johnson & Johnson (NYSE:JNJ)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPVHIwWDNwWXdpdG92WkpGMVBMTFBVLXE1U29PMTVSbjRjTDItd3FoMW5tRzlFVGNXRHdqRjRVOXBPY0dXMzM0UU9GQVdGYkF2QVZnZmpERFc2UDM0U3g0T21ONjRvR2E2RjJHQXBjVTVJNXZkOC1GMjJsSWNZUk55Qzc3NmtHMHRrcjZpTXlwWmYyWmFMNnRNRWlqbTlRVlA5VGFDNWtwN2ZtRWRqU3JNcE0yRUxocXloZnlPeHNiRmgtZw?oc=5", "source_name": "Benzinga", "published_at": "2026-07-15T13:31:51+00:00", "published_display": "15 Jul 2026 13:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "J&J MedTech growth slows again in Q2 as Abiomed weighs on results", "summary": "Johnson & Johnson's MedTech business experienced a slowdown in Q2 operational sales growth to 3.6%, reaching $8.93 billion, primarily due to ongoing challenges with Abiomed. Abiomed, acquired by J&J in 2022, saw its sales fall 2% year over year in the quarter, largely attributed ", "url": "https://www.fiercebiotech.com/medtech/jj-medtech-sales-trajectory-continues-ease-q2-abiomed-drags-sales", "source_name": "Fierce Biotech", "published_at": "2026-07-15T13:57:41", "published_display": "15 Jul 2026 13:57", "sentiment": "negative", "sentiment_pct": 29, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson MedTech sales grow 4.5% in Street-beating Q2, ups guidance", "summary": "Johnson & Johnson (J&J) reported strong Q2 2026 results, surpassing Wall Street expectations with 4.5% growth in MedTech sales and overall sales of $25.3 billion. The company also raised its full-year revenue and adjusted EPS guidance, now expecting annual revenue to exceed $100 ", "url": "https://www.massdevice.com/johnson-johnson-medtech-sales-grow-q2-2026/", "source_name": "MassDevice", "published_at": "2026-07-15T10:54:14", "published_display": "15 Jul 2026 10:54", "sentiment": "positive", "sentiment_pct": 80, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson and Johnson Earnings Report | 2026 Q2 Infographic", "summary": "Johnson & Johnson released its second-quarter 2026 earnings report, highlighting strong performance in its Innovative Medicine and MedTech businesses. The company reported a 6.6% increase in sales to $25.3 billion, with operational growth of 5.6%, and an adjusted EPS of $2.90. Jo", "url": "https://www.jnj.com/latest-news/what-you-need-to-know-about-johnson-johnsons-2026-second-quarter-earnings", "source_name": "Johnson & Johnson", "published_at": "2026-07-15T10:41:14", "published_display": "15 Jul 2026 10:41", "sentiment": "positive", "sentiment_pct": 73, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Genmab Announces Net Sales of DARZALEX\u00ae (daratumumab) for Second Quarter of 2026", "summary": "Genmab announced that worldwide net trade sales of DARZALEX (daratumumab) for the second quarter of 2026 totaled USD 4,207 million. This figure includes sales of both intravenous and subcutaneous products, as reported by Johnson & Johnson. Genmab receives royalties on these globa", "url": "https://www.manilatimes.net/2026/07/15/tmt-newswire/globenewswire/genmab-announces-net-sales-of-darzalex-daratumumab-for-second-quarter-of-2026/2384865", "source_name": "The Manila Times", "published_at": "2026-07-15T10:40:39", "published_display": "15 Jul 2026 10:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson Hikes Guidance, Stock Falls", "summary": "Johnson & Johnson exceeded second-quarter earnings and revenue expectations, prompting the company to raise its full-year guidance. This growth was primarily driven by the strong performance of its oncology portfolio, despite a decline in sales for its drug, Stelara. Despite the ", "url": "https://www.barrons.com/articles/johnson-johnson-jnj-earnings-stock-price-08c10790", "source_name": "Barron's", "published_at": "2026-07-15T10:34:37", "published_display": "15 Jul 2026 10:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson Bumps Up Guidance as Sales Rise", "summary": "Johnson & Johnson has raised its full-year guidance for sales and adjusted earnings per share after reporting higher sales in the latest quarter. The company now expects full-year sales of $100.8 billion to $101.4 billion and adjusted earnings per share between $11.60 to $11.75, ", "url": "https://www.wsj.com/health/healthcare/johnson-johnson-bumps-up-guidance-as-sales-rise-61ca952c", "source_name": "WSJ", "published_at": "2026-07-15T10:32:37", "published_display": "15 Jul 2026 10:32", "sentiment": "positive", "sentiment_pct": 75, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "J&J quarterly earnings beat Wall Street estimates on strength of medicines unit", "summary": "Johnson & Johnson surpassed Wall Street expectations for its second-quarter sales and profit, primarily driven by strong performance in its pharmaceutical unit, particularly from Darzalex and Tremfya. The company also raised its full-year sales and profit outlook, despite a sligh", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/jj-quarterly-earnings-beat-wall-street-estimates-strength-medicines-unit-2026-07-15/", "source_name": "Reuters", "published_at": "2026-07-15T10:27:14", "published_display": "15 Jul 2026 10:27", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson Q2 Preview: Stock Near All-Time Highs, Market Expert Sees Rally to $282 \u2013 \u2018Continue The", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgJBVV95cUxNa2JSZzVYTEYwVWFiSWFkTjF6NUFpU2J4ZEpvMmF4aDV3MXhNYWs3TGJyakVZLWNCQlU2NjNKdG94UVJicFBpVnpVdmJWQnpubkt5bWpDSW44ZWdJM1FNR0hjSy04NUZEZFFJazkxRTVEOGF4cHlKSUZrQmF5UXQzYnpyWldNelB1OVRVVEVtd3dkV192R2hQM3RaWWVyMHlmcTFDYjFackI4LXFRUk5wRnhzam9tQXp0alFDVVQ3djlyZnlxZW15VzBkQjd0Snc5bEZxZFJoWVRBZHU5M1Q4SlJrWXFsQ1k0OUMzMGk4NWxaeVE0V2p3b3dWZFdpVzFsUFgxM3F3?oc=5", "source_name": "Benzinga", "published_at": "2026-07-14T15:55:20+00:00", "published_display": "14 Jul 2026 15:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson (JNJ) Stock May Be Reasonable After Talc Verdict Ruling", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxObGNVaVNMUU1CbVNRelFqa1cxSjZJRXcxY2VyaGRrTEE4dC1fZm84Wml5WllQc29DeVJSU2cxelhTS2hNdHptWXdmYTRaS1pFc3JZMjdzZXdlb1Rhdk8wUDJJb3dMSGl3R3JxeU5fX05ndzM2UmlyOE9ISU41c0oxRUJnZVN4TVQxb0RqYkFWMjhGUXFlcTJZOC1n?oc=5", "source_name": "Market source", "published_at": "2026-07-14T14:14:37+00:00", "published_display": "14 Jul 2026 14:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Can Johnson & Johnson (JNJ) Trade At A Discount Despite Talc Risk?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-13T23:47:33+00:00", "published_display": "13 Jul 2026 23:47", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Johnson & Johnson Stock Poised for New Highs as Q2 Results Approach?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQUFo2amhLcHg0T2J4TzFob3QtTDdITUwyZGhwZEM0VGphc2NuY0JMcGZmRXBxLS15bTBkR2dhRmpVeFFnczdkT2ZVTmdPTjhjTkxRUVRZZDNvNzRTbHY5RWN1bFphRi1mbGg1UVBQT0s2cGFwOU9Ca1NDNV9QM2VVVGFlQkdOcklxUV9xb2VMMlRLa1V0NEk4YXZoeXB3Q2NzS1l5THAxeTRXNEMxUmtjTWdlQTVRdkQwYUxlWUZQRV8yUQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-13T21:50:00+00:00", "published_display": "13 Jul 2026 21:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mosaic Family Wealth Partners LLC Purchases 4,020 Shares of Johnson & Johnson $JNJ", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxNN01FQnIwd3FscVNwVG5LbVhpNGhGYWxTS3V2R1FlYWVvS2RxbjB0ejJSS1ltaUo0N0NDSnZ6YXc3TWVNMEtyMzczWjJzUTMxWnRMZ0w1Z2M5UWtGOWwzTWNZV243X0NuVW9qSk9YTy04RGRhMUtYNi03cHNKeFhubC1uSHlPQ08xd25WaG5mc1FVV0RzOS1MMUxPVFdvaXlkZDFyZDBGcWFMcXZUNzdPMC1XNUtuLVZBV3ZjQzItSVRRMFR3TEY1SEI4QU5kWm8xQnRCWmF3?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-12T16:49:09+00:00", "published_display": "12 Jul 2026 16:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson (JNJ) Faces Upheld $45 Million Talc Verdict In Illinois", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-10T23:50:14+00:00", "published_display": "10 Jul 2026 23:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bank of America Issues Positive Forecast for Johnson & Johnson (NYSE:JNJ) Stock Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxQT21Ra1Q2SDdQZkNyN0lYMFpOajJDS1pvekxCTDJCdHh5Q3N5M1NVcExBQmdubDB3OTRWN3d1clJoVHFPQVFxclBDdHVhUDlQR1hSc2tWNHBiUl9pQ1ZSSmo4OTMwRlJ3bXNSbkoxR2QxZzNUOFlVazFtNnFpVkJ2SDZxbjlSZmlBYVFCcDNMc0ROclNqaWlnZUdUc2ZSenhOV18wTTBPN3FZdTB4Wl81dVRFTXpPUTVlNzEzRklXWkdzLVlwaUJKeWpIYmExWjQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-10T18:16:06+00:00", "published_display": "10 Jul 2026 18:16", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson (JNJ) Highlights IMAAVY Data, Is The Stock Above Fair Value?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-08T08:38:50+00:00", "published_display": "08 Jul 2026 08:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson $JNJ Stock Holdings Increased by New York State Teachers Retirement System", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxNNVk2RzRVWUhpUndIOFgzbnBoRjBPdnR4QksydDE5SXR4SkNMY1QyZmhWVFRjdmszQmI5V3ktMnZaODU2VUdzbmNyeERxM1g2VjFJbXE5MzZkTWdSVHRtemlCbkFaWmdVXzVPLUhSNGRUMFdnbDRuV0gxbkl4VUgyVkZWWENraW8za2VsZ0d5ZXhqQ3d2X0VraEdYMjhWNjFGa0RMT2JpSk9iWHEtZFRZbE5qRnhzRmRtd25RX09zVXNOWW9laEZhaU95TmNCNDNaeENDVHU2TlVLMTZFZ2xYS1Jlay0?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson (JNJ) Stock Looks Undervalued On Cash Flow While Earnings Look Fair", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-05T07:57:22+00:00", "published_display": "05 Jul 2026 07:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Johnson & Johnson (JNJ) Using IMAAVY\u2019s gMG and Pregnancy Data to Deepen Its Immunology Moat?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-03T00:21:16+00:00", "published_display": "03 Jul 2026 00:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson (JNJ) Stock After 73% One-Year Rally Is There Value Left", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNMXRiN0hmU0xUMUpjVDVzTXAtZ2xOZHZpdENrWW9FMFhyMUJHVmVkY1l5V05WY0dqX1E2UnRhTUxNR0FfZExuNGNJdUlQNDNlcE5pQUtQNVVsN0NiazhJbXRzdXMxT2VPcWpEOGVBY213V2xEZHNfckpZTkpLWDZhNGJiZ3Nfc0pCbzIzcFVzVzBZdXFWNXZxUw?oc=5", "source_name": "Market source", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson (JNJ) Surges 4.0%: Is This an Indication of Further Gains?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPaGw0RkxkMWNTaHJUdHBjZjFRTDQtdXZma3piLWxRLU1rSHI5dncyNUF2NUtYRGx5NG9BeVhwX2RmYXpkX2FjbUw3WXRSWkpGSVp6dGEta2M1WnFnZURZX0hoUGo1SnN2T0xCOWlBUV9jQW1hOXF1MzU3dzloSVhkVHRZSmZWUjlabldSRmZFRmVwci0zTE5CVA?oc=5", "source_name": "Market source", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "122,800 Shares in Johnson & Johnson $JNJ Acquired by Louisiana State Employees Retirement System", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxPdko4dGw5djBtZWxNenhOV3VWUWV5b29XM0NzWHZjQURMT19JcEhrN1FWYlk4aWtFSmI3S2gxNTN0TFEzOHFUS1h0OElsZFhnYVlKZ19IRGw1NG1BZVVuYmxxcWJQMlE1WS1aY2s2Rzd0dl8zWHhWZEJseDJwZDRNdjFPUFBEQ25OYjVBUVVmVGN3UFNZNlR2ZUZnM0oxQWxQeXVnVVlicV9hNWVEVXp6d1M2b2M2ZHhYd0RGdVFIS3VJSGZkOGMxZXltNjVVaTY3OXBTYnFYX19wcTdKdkpnTHpOazlKYUZT?oc=5", "source_name": "MarketBeat", "published_at": "2026-06-28T08:51:35+00:00", "published_display": "28 Jun 2026 08:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Johnson & Johnson (JNJ) Is Using U.S. Manufacturing Investment to Strengthen Its Vision Business", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxOejcyV2pfSnUtb2wyQ1VvQWZrdzhmc2VubDVaSU5KaEQtbGVTOG93a0lVUkQyS1JKZHZzM01ISXpLQS1DNXNrUGhmbUhwQkVPazZOYzhoY01PM1Rfek9fX3U4cGpqVy1KTTFyZTVmQVZLVEVURHdVWnVQNkV2QkI2b2hJYm9jY2ptaG1oTjBSQWZDdw?oc=5", "source_name": "Market source", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson's US$1bn Investment for Vision & Eye Care", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxQV2ZMcEhSQW9uakJIRVRpN1Vmck5NSm1QOU8xNDNjcWd5VkN3VHFNT2g3NzNNZVlGbUg4OGlDSkNDQm1WMmVCc3RndGtXZ3lycFJMV0U3ODBscXc2NjhQc3hpNlhWV01wamRsaklUeHVLVlFrcmpQLUVoVEhxY0g5MjVtS3FkbzZteHJ3R3lSTTlJd2pD?oc=5", "source_name": "Healthcare Digital", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson to Invest Over $1 Billion in Florida Contact Lens Manufacturing Facility", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxPWG9YV2ZuRmJqdjlKMlMxaVdwcGNERXdNM1h6WEJJTmpNNG1GR0pvV3MyTkliLVdIT2V4Z1VWb2Zzc3E1NEpPbkNHNDVVNnM4Z1FfVzBPWW5nMFVSZV8yZ2x0UktIVWtUUmRLU3hqNHZrVWtfNmFhQTFFZFRabTFJcnl1V3R5WXRsdkdDWmpXdXlUeEt4?oc=5", "source_name": "Market source", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson Invests more than $1 Billion to Strengthen U.S. Vision Manufacturing in Jacksonville, Florida", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxNRkJWRlgweUJsTXJlVnRCeVpzX1o4eWZIUlo2WjRMRUNxVk5yNHc5enZtRUppUmlJM19CM0xxSjVyZDktWldtM3ZlOHp0Z2V1elNfalZIS0tVRDRydGlqSTFSY3NHbF9WRkE0b1JDZldVOUhUV25hX2hCNGZsZlVPRUY2b3VzN2k5bGp1Rm9vbjJob1hfT2RHX2NVQXBjQWJFTHA0SE54T25aMnNVWDMzdkhWLVN3cEVjR01hb3ZCbWxPdVVoTnhyeld1SDRfUDY4RExVS0gwcl9WbFI1VXB6M1RUUTgxUERFQkE?oc=5", "source_name": "Johnson & Johnson", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jim Cramer Says He Likes Drug Stocks Here As He Discusses Johnson & Johnson", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQUUotS2JraFhGNmxCNzVlSTZ1TUVYTWVPX0Rpb1ZKRUozMUNQR2g4dkJQY21nWGVsbDY4V2R4S0hhNTdQRkZUZ1Zqb3RDclJzcjlzcG5HOFhqN05DbWpZN1ZBci1nWFJoMHFGZzRUZWZKa1c3QXJZUmJnWlJOa2R6T0NiTDhsQU51MTFEV2l2RHg3T0l6cEZhczlDcw?oc=5", "source_name": "Market source", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson MedTech Chief Just Revealed What\u2019s Coming for the EP Market. Here\u2019s What Investors Should Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNbHB2endjWEtuTEFOeW55SS1zSjVxMmxseTl0bzRJNi1aVGZWWXlGQ0kybVBsb2NYeW4za0o5M29hR0lsNUNLcTFTdDltME9EVVRCUGkyVWRzTzdES2MyVm1lUGpWT3R2Z2hNeWtKQ01wUDlXR2owRmVsYVRhV3VZYUNPYkk0TGFXTXREVUZZZnlPSTdIVFQzUVJJRmpyQ1RDWHc4QmZfMDFSMWZOaUNMN3daY2p6OWNKNnJTOHN4MUdtZVp6UW1PaUxoVURtZw?oc=5", "source_name": "TIKR.com", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson: Why This Popular Core Stock Is a Sell", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE94Rkg2UTB1bHFKMFRZRWJQX21MOEozTnBXVGpUR2tzaWJGbEliY2FVSkw1RVRXUHYzXzd4bGpnSzNNWncySzlfSFZJRXNxbHpBdE9ucGtwaFVVVWFuZXVNZ2RVZFNYaDBvVENhWVRQRUxCRWxVcFo2N21B?oc=5", "source_name": "Morningstar", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Reassess Johnson & Johnson (JNJ) After Recent Litigation Headlines?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPQW0tcm4yVklUOUl5TWtTeXdqQTFpdXpZdHVNX19QMnhfd3lXVGZyVFRTWmxXZHg3M0NzSVBpenBiS2U2bTNBUzhTYXRTaHNhWEl3eGk0TDh0bEVscWlETjZhaHBOMjdKbFZFWEVmcVZMN0RvNDBLMFAySU1BZ0FDT0ZDMVdhWFFOUXpuLWFBMWl2Tkc2S3lydEhzWmp4enM?oc=5", "source_name": "Market source", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Goldman Sachs Adjusts Price Target on Johnson & Johnson to $282 From $275, Maintains Buy Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/goldman-sachs-adjusts-price-target-103732675.html", "source_name": "MT Newswires", "published_at": "2026-07-16T10:37:32+00:00", "published_display": "16 Jul 2026 10:37", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stifel Adjusts Price Target on Johnson & Johnson to $260 From $250, Maintains Hold Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/stifel-adjusts-price-target-johnson-095609531.html", "source_name": "MT Newswires", "published_at": "2026-07-16T09:56:09+00:00", "published_display": "16 Jul 2026 09:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Scotiabank Adjusts PT on Johnson & Johnson to $305 From $265, Maintains Sector Outperform Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/scotiabank-adjusts-pt-johnson-johnson-095603813.html", "source_name": "MT Newswires", "published_at": "2026-07-16T09:56:03+00:00", "published_display": "16 Jul 2026 09:56", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Raymond James Adjusts PT on Johnson & Johnson to $265 From $258, Maintains Outperform Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/raymond-james-adjusts-pt-johnson-095554576.html", "source_name": "MT Newswires", "published_at": "2026-07-16T09:55:54+00:00", "published_display": "16 Jul 2026 09:55", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Morgan Stanley Adjusts PT on Johnson & Johnson to $294 From $284, Maintains Overweight Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/morgan-stanley-adjusts-pt-johnson-095541168.html", "source_name": "MT Newswires", "published_at": "2026-07-16T09:55:41+00:00", "published_display": "16 Jul 2026 09:55", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "JPMorgan Adjusts Price Target on Johnson & Johnson to $270 From $260, Maintains Neutral Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/jpmorgan-adjusts-price-target-johnson-095529516.html", "source_name": "MT Newswires", "published_at": "2026-07-16T09:55:29+00:00", "published_display": "16 Jul 2026 09:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wells Fargo Adjusts Price Target on Johnson & Johnson to $272 From $263, Maintains Overweight Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/wells-fargo-adjusts-price-target-095523264.html", "source_name": "MT Newswires", "published_at": "2026-07-16T09:55:23+00:00", "published_display": "16 Jul 2026 09:55", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Leerink Partners Adjusts PT on Johnson & Johnson to $276 From $265, Maintains Outperform Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/leerink-partners-adjusts-pt-johnson-095515809.html", "source_name": "MT Newswires", "published_at": "2026-07-16T09:55:15+00:00", "published_display": "16 Jul 2026 09:55", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Principal Financial Group Inc. Sells 38,576 Shares of Johnson & Johnson $JNJ", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxPMVRTajFqYUxON3dENnBUZWZjeTFDaGVqUEJqYVc0VlBweVhsY1hVQV9DX3JBR2ZZa3BfVzJlQ2lWZ1BibDZucVFuY2ZONkI0X2NBZk5CczNBanVKalQ5QW1YcC1GOUVZNWJsTlM2VFh6cTl6c0FmNlBncC0wRmdvRXNpOHlycXl0cUo0VERBal9jeDFYX09fVnJQcDhlcDZrdk42ZjkyY2ZmOEwyRHdmbjRGX3JsYUVjNTQ2dGZpdU9VMS1EeGV6YWh5bGE?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-16T09:05:52+00:00", "published_display": "16 Jul 2026 09:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson $JNJ Shares Acquired by TFR Capital LLC.", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNR3dVMEk4cVI3X3A0ang2bnVGYk9ic1JYWG96MEN2R1YxaFFiQWV1QXNIWS13ck5fWTBhT2lLT1lHYzV5TVk3Zm5NOEdQUTRrLXlpQW5fN19BZXRzeUNNYXVXaF9OM0wwek1hQ0YyZU9wMFFJSWFVMjlaSVlwZWw4TUFfTmVJSkVYYWZsREhjeEpvaDdqMmpUSEY2a0t3RjZoMHpOZFhqalYwT1JGWEVVMkg0ZHNCZw?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-16T09:03:59+00:00", "published_display": "16 Jul 2026 09:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Calamos Wealth Management LLC Sells 6,096 Shares of Johnson & Johnson $JNJ", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxOWHdhdDB5bWxJYWpyWUFObXVCcmQ4ZVhPNTZPNXQtQ1hIdldMOW9SUkxQR3JDcm10STRPeVFKRGtFRGZaX1R4a25aNlZ1V09PaE0wbmNtVmNSQUN4ZVg2a0RZcF95aFBLUDJJTVlGYXRjdWljQnA2Z2V2VHNuWW52UC1vV0g5YUdZRTZjSUtHNWZOUEZtYnJWX1FNSENXSmtOQzdtNjRCOURleE5WNTNYQ1FfMk5DYXZVN3FBLUhTTk5BWmpQYnlLVDdKQQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-16T08:07:37+00:00", "published_display": "16 Jul 2026 08:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Calamos Advisors LLC Purchases 122,350 Shares of Johnson & Johnson $JNJ", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQMXZHOVB5QTN4alZVRFJSem9HLWZPeGJaTHhMSlJrR2xONEtFSDVNaWNpdm5DcE50eElaLXZCY1hYZlVOR21DR1dnNndISEZ0MXBUNWQ5RDhqUUpQX1RnNzNQV1FCRTlFSUNPUHlFc19NcEM2b1FfWEZQYVBDSG9XcUdncXE2X1lIcVJOUTZ5VGVhOXloajZSMGdwUFZlOXZHUi14WHdJU2RpZXg1QmJUeklNMkI3NS1mbEpkWkExSEo3RVVVWE9j?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-16T07:43:32+00:00", "published_display": "16 Jul 2026 07:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Birinyi Associates Inc. Invests $4.16 Million in Johnson & Johnson $JNJ", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPaWE0VjFjbmRoejBJbnpBdmI0RXVZVkpZZ0NnQnMxR3lTSV9XMUktSlcyMFpJZTBKa1ZBeC1TMnJpTjlyZXVfSTZrVmI2dmhUTzduLUt5WkRMTnBLZmRIalFaWjR6aVNMV0haN3lnSl92VUxXVU5JMkZCWjlmVHZTVU8za3J0UXBObEJWR3l6VHRFLW9IWjU3TEF0dk90WTNQMzUzTWhBdEs3TmprUUtUT0tCTmVGa1F6MnZkLUg3Ti16WjhG?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-16T07:43:32+00:00", "published_display": "16 Jul 2026 07:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ghe LLC Has $138,000 Stock Holdings in Johnson & Johnson $JNJ", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNOFNjNXJpUmpQcGpvSlBacVlEMjZfQjg4RUQ0SU55a0taSGxKVVlZZm9YSjVUNnh3cjZpTU5UZy1XblVFVkhsNlZfdjU4VmdpWGRFYVYwWTlFb29sTkVWNG90MTBwUW9Gbk9yVVpRUlc3UG9yMS1vRXBpYjdHTVZoYXcxTWRjdnNMZUZGYnMycTB2cXZwdE80Z1Yxb3phVVlOcW5fXzNHRDR0dDN2N1ZQXy1UWTlMbXNo?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-16T07:43:31+00:00", "published_display": "16 Jul 2026 07:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bleakley Financial Group LLC Boosts Holdings in Johnson & Johnson $JNJ", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxNLW5jN2p2VmhHWEhBOG1hbV9ldWtMaEYzalVTWUJqT0N6aS1KQnFBZ0c2aUpIT0NBVjZNUVA4Zl91bmRNd1kwc3NoeVZhSVcxTGlSS3lybUx4YmFocEJpV2NWT28yRm9UdndYd1NOTXY3Y3hsZkFrNC13a2N6b29RU0c5NnV3b0lhNzh4RGNtNUdvYmpHMmdmSmNrc3I5NjFNcmtBaHhXVUl1UW5INGVuMEh2eVBCdHhRcnplaFcwS3JMUHhwcmpr?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-16T07:25:31+00:00", "published_display": "16 Jul 2026 07:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson $JNJ Shares Purchased by AMG National Trust Bank", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPU1JGa2x4SlhsaWZYZi1TdnhEZ0E4X3lIQ25DVGdzSUdIaDRxVm5RdWpseC1OcnJsaG5DZnNudGlpbFlaNTduNnhRaGtFR19WZW5HM0hDNHd2WWw5MTMwTDB2TWFTU3V0dHBUQ0VkUDFoQjJvUTZTTlk2VzFYNjZLQUJFSE9VbThLem9nX0RrOXF4c0pBVkt3anlXaHMzU2REeUdQNkItUlFic0owU0xsTTBpZUFRRHpQX0M4QzliRzVmQQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-16T07:08:36+00:00", "published_display": "16 Jul 2026 07:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson commits to $55B, 4-year US investment plan", "summary": "Johnson & Johnson's CFO Joe Wolk announced the company's commitment to a $55 billion, four-year investment plan in the US. Wolk discussed this plan, along with the company's Q2 earnings and the performance of its medical technology unit, including Impella heart pumps, during an i", "url": "https://www.foxbusiness.com/video/6401230115112", "source_name": "Fox Business", "published_at": "2026-07-15T20:07:05", "published_display": "15 Jul 2026 20:07", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson Earnings: Steady Growth and Good Near-Term Visibility", "summary": "Johnson & Johnson reported a 6.6% revenue growth in the second quarter, driven by strong performances in Innovative Medicine and MedTech, leading management to increase 2026 guidance. While shares dropped 2% intraday, Morningstar is maintaining its $190 fair value estimate, notin", "url": "https://www.morningstar.com/stocks/johnson-johnson-earnings-steady-growth-good-near-term-visibility", "source_name": "Morningstar", "published_at": "2026-07-15T19:15:57", "published_display": "15 Jul 2026 19:15", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson CFO Says Guidance Hike Is Just the Start", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxOMTZYX0hFVUhHanBBV2p1TmxlaTRIOHYybmNSZzhoUnl2c2RVRkJrdU01MEtqc00xM205TmRYNEllSFp5Tmd1cXBfWEV4RG5WWkRULV8xZFBWck9LT0dVX1VySnpheE5uRlpFUzZDZHhmZm8wRW5sNFBnYjJrelFCaEpLTTdDOWFOZ0E?oc=5", "source_name": "Barron's", "published_at": "2026-07-15T18:13:00+00:00", "published_display": "15 Jul 2026 18:13", "sentiment": "positive", "sentiment_pct": 58, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amid $55B US manufacturing push, J&J turns to streamlining its pharma supply chain", "summary": "Johnson & Johnson is restructuring its pharmaceutical supply chain, announcing up to $750 million in costs to streamline operations, including offloading certain sites. This move follows a $55 billion commitment to bolster U.S. manufacturing capabilities for medicines in the U.S.", "url": "https://www.biospace.com/business/amid-55b-us-manufacturing-push-j-j-turns-to-streamlining-its-pharma-supply-chain", "source_name": "BioSpace", "published_at": "2026-07-15T17:56:57", "published_display": "15 Jul 2026 17:56", "sentiment": "positive", "sentiment_pct": 67, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2026", "summary": "Johnson & Johnson (NYSE: JNJ) has declared a cash dividend of $1.34 per share for the third quarter of 2026. This dividend will be payable on September 8, 2026, to shareholders recorded by August 25, 2026. The ex-dividend date is also set for August 25, 2026.", "url": "https://www.biospace.com/press-releases/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2026", "source_name": "BioSpace", "published_at": "2026-07-15T17:08:44", "published_display": "15 Jul 2026 17:08", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson\u2019s Spravato sales growth supports psychedelic drug opportunity: Jefferies", "summary": "Jefferies notes that strong Q2 sales of Johnson & Johnson's Spravato, a depression treatment, indicate a promising long-term commercial opportunity for psychedelic drugs in treating mental health disorders. The drug's annual revenue run rate of over $2.3 billion and its potential", "url": "https://www.proactiveinvestors.com/companies/news/1095518/johnson-johnson-s-spravato-sales-growth-supports-psychedelic-drug-opportunity-jefferies-1095518.html", "source_name": "Proactive financial news", "published_at": "2026-07-15T15:34:04", "published_display": "15 Jul 2026 15:34", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "No patent protection for Stelara? No problem for J&J as Tremfya fills the void", "summary": "Johnson & Johnson has increased its annual sales guidance after a strong second quarter, largely driven by the performance of its immunology portfolio. Despite a significant drop in Stelara sales due to patent expiry, the company's new drug Tremfya largely compensated for the dec", "url": "https://www.fiercepharma.com/pharma/no-patent-protection-stelara-no-problem-jj-tremfya-fills-void", "source_name": "Fierce Pharma", "published_at": "2026-07-15T15:30:49", "published_display": "15 Jul 2026 15:30", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "J&J raises FY26 outlook following positive Q2", "summary": "Johnson & Johnson (J&J) reported strong Q2 revenues of $25.3 billion, a 6.6% year-over-year increase, primarily driven by its Innovative Medicine business and J&J MedTech. Following these results, the company raised its 2026 earnings outlook to $11.60-$11.75 per share. Despite th", "url": "https://finance.yahoo.com/healthcare/articles/j-j-raises-fy26-outlook-151414239.html", "source_name": "Market source", "published_at": "2026-07-15T15:13:49", "published_display": "15 Jul 2026 15:13", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "J&J axes eye disease gene therapy after key phase 2b readout", "summary": "Johnson & Johnson has discontinued the development of JNJ-1887, an eye disease gene therapy for geographic atrophy, after reviewing topline data from its phase 2b Parasol study. The company had acquired the asset in 2020 and initiated the 305-subject trial in 2023, aiming to slow", "url": "https://www.fiercebiotech.com/biotech/jj-axes-eye-disease-gene-therapy-after-key-phase-2b-readout", "source_name": "Fierce Biotech", "published_at": "2026-07-15T14:38:50", "published_display": "15 Jul 2026 14:38", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What's Going on With Johnson & Johnson Stock Wednesday? - Johnson & Johnson (NYSE:JNJ)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPVHIwWDNwWXdpdG92WkpGMVBMTFBVLXE1U29PMTVSbjRjTDItd3FoMW5tRzlFVGNXRHdqRjRVOXBPY0dXMzM0UU9GQVdGYkF2QVZnZmpERFc2UDM0U3g0T21ONjRvR2E2RjJHQXBjVTVJNXZkOC1GMjJsSWNZUk55Qzc3NmtHMHRrcjZpTXlwWmYyWmFMNnRNRWlqbTlRVlA5VGFDNWtwN2ZtRWRqU3JNcE0yRUxocXloZnlPeHNiRmgtZw?oc=5", "source_name": "Benzinga", "published_at": "2026-07-15T13:31:51+00:00", "published_display": "15 Jul 2026 13:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "J&J MedTech growth slows again in Q2 as Abiomed weighs on results", "summary": "Johnson & Johnson's MedTech business experienced a slowdown in Q2 operational sales growth to 3.6%, reaching $8.93 billion, primarily due to ongoing challenges with Abiomed. Abiomed, acquired by J&J in 2022, saw its sales fall 2% year over year in the quarter, largely attributed ", "url": "https://www.fiercebiotech.com/medtech/jj-medtech-sales-trajectory-continues-ease-q2-abiomed-drags-sales", "source_name": "Fierce Biotech", "published_at": "2026-07-15T13:57:41", "published_display": "15 Jul 2026 13:57", "sentiment": "negative", "sentiment_pct": 29, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson MedTech sales grow 4.5% in Street-beating Q2, ups guidance", "summary": "Johnson & Johnson (J&J) reported strong Q2 2026 results, surpassing Wall Street expectations with 4.5% growth in MedTech sales and overall sales of $25.3 billion. The company also raised its full-year revenue and adjusted EPS guidance, now expecting annual revenue to exceed $100 ", "url": "https://www.massdevice.com/johnson-johnson-medtech-sales-grow-q2-2026/", "source_name": "MassDevice", "published_at": "2026-07-15T10:54:14", "published_display": "15 Jul 2026 10:54", "sentiment": "positive", "sentiment_pct": 80, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson and Johnson Earnings Report | 2026 Q2 Infographic", "summary": "Johnson & Johnson released its second-quarter 2026 earnings report, highlighting strong performance in its Innovative Medicine and MedTech businesses. The company reported a 6.6% increase in sales to $25.3 billion, with operational growth of 5.6%, and an adjusted EPS of $2.90. Jo", "url": "https://www.jnj.com/latest-news/what-you-need-to-know-about-johnson-johnsons-2026-second-quarter-earnings", "source_name": "Johnson & Johnson", "published_at": "2026-07-15T10:41:14", "published_display": "15 Jul 2026 10:41", "sentiment": "positive", "sentiment_pct": 73, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Genmab Announces Net Sales of DARZALEX\u00ae (daratumumab) for Second Quarter of 2026", "summary": "Genmab announced that worldwide net trade sales of DARZALEX (daratumumab) for the second quarter of 2026 totaled USD 4,207 million. This figure includes sales of both intravenous and subcutaneous products, as reported by Johnson & Johnson. Genmab receives royalties on these globa", "url": "https://www.manilatimes.net/2026/07/15/tmt-newswire/globenewswire/genmab-announces-net-sales-of-darzalex-daratumumab-for-second-quarter-of-2026/2384865", "source_name": "The Manila Times", "published_at": "2026-07-15T10:40:39", "published_display": "15 Jul 2026 10:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson Hikes Guidance, Stock Falls", "summary": "Johnson & Johnson exceeded second-quarter earnings and revenue expectations, prompting the company to raise its full-year guidance. This growth was primarily driven by the strong performance of its oncology portfolio, despite a decline in sales for its drug, Stelara. Despite the ", "url": "https://www.barrons.com/articles/johnson-johnson-jnj-earnings-stock-price-08c10790", "source_name": "Barron's", "published_at": "2026-07-15T10:34:37", "published_display": "15 Jul 2026 10:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson Bumps Up Guidance as Sales Rise", "summary": "Johnson & Johnson has raised its full-year guidance for sales and adjusted earnings per share after reporting higher sales in the latest quarter. The company now expects full-year sales of $100.8 billion to $101.4 billion and adjusted earnings per share between $11.60 to $11.75, ", "url": "https://www.wsj.com/health/healthcare/johnson-johnson-bumps-up-guidance-as-sales-rise-61ca952c", "source_name": "WSJ", "published_at": "2026-07-15T10:32:37", "published_display": "15 Jul 2026 10:32", "sentiment": "positive", "sentiment_pct": 75, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "J&J quarterly earnings beat Wall Street estimates on strength of medicines unit", "summary": "Johnson & Johnson surpassed Wall Street expectations for its second-quarter sales and profit, primarily driven by strong performance in its pharmaceutical unit, particularly from Darzalex and Tremfya. The company also raised its full-year sales and profit outlook, despite a sligh", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/jj-quarterly-earnings-beat-wall-street-estimates-strength-medicines-unit-2026-07-15/", "source_name": "Reuters", "published_at": "2026-07-15T10:27:14", "published_display": "15 Jul 2026 10:27", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson Q2 Preview: Stock Near All-Time Highs, Market Expert Sees Rally to $282 \u2013 \u2018Continue The", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgJBVV95cUxNa2JSZzVYTEYwVWFiSWFkTjF6NUFpU2J4ZEpvMmF4aDV3MXhNYWs3TGJyakVZLWNCQlU2NjNKdG94UVJicFBpVnpVdmJWQnpubkt5bWpDSW44ZWdJM1FNR0hjSy04NUZEZFFJazkxRTVEOGF4cHlKSUZrQmF5UXQzYnpyWldNelB1OVRVVEVtd3dkV192R2hQM3RaWWVyMHlmcTFDYjFackI4LXFRUk5wRnhzam9tQXp0alFDVVQ3djlyZnlxZW15VzBkQjd0Snc5bEZxZFJoWVRBZHU5M1Q4SlJrWXFsQ1k0OUMzMGk4NWxaeVE0V2p3b3dWZFdpVzFsUFgxM3F3?oc=5", "source_name": "Benzinga", "published_at": "2026-07-14T15:55:20+00:00", "published_display": "14 Jul 2026 15:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson (JNJ) Stock May Be Reasonable After Talc Verdict Ruling", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxObGNVaVNMUU1CbVNRelFqa1cxSjZJRXcxY2VyaGRrTEE4dC1fZm84Wml5WllQc29DeVJSU2cxelhTS2hNdHptWXdmYTRaS1pFc3JZMjdzZXdlb1Rhdk8wUDJJb3dMSGl3R3JxeU5fX05ndzM2UmlyOE9ISU41c0oxRUJnZVN4TVQxb0RqYkFWMjhGUXFlcTJZOC1n?oc=5", "source_name": "Market source", "published_at": "2026-07-14T14:14:37+00:00", "published_display": "14 Jul 2026 14:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Can Johnson & Johnson (JNJ) Trade At A Discount Despite Talc Risk?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-13T23:47:33+00:00", "published_display": "13 Jul 2026 23:47", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Johnson & Johnson Stock Poised for New Highs as Q2 Results Approach?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQUFo2amhLcHg0T2J4TzFob3QtTDdITUwyZGhwZEM0VGphc2NuY0JMcGZmRXBxLS15bTBkR2dhRmpVeFFnczdkT2ZVTmdPTjhjTkxRUVRZZDNvNzRTbHY5RWN1bFphRi1mbGg1UVBQT0s2cGFwOU9Ca1NDNV9QM2VVVGFlQkdOcklxUV9xb2VMMlRLa1V0NEk4YXZoeXB3Q2NzS1l5THAxeTRXNEMxUmtjTWdlQTVRdkQwYUxlWUZQRV8yUQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-13T21:50:00+00:00", "published_display": "13 Jul 2026 21:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mosaic Family Wealth Partners LLC Purchases 4,020 Shares of Johnson & Johnson $JNJ", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxNN01FQnIwd3FscVNwVG5LbVhpNGhGYWxTS3V2R1FlYWVvS2RxbjB0ejJSS1ltaUo0N0NDSnZ6YXc3TWVNMEtyMzczWjJzUTMxWnRMZ0w1Z2M5UWtGOWwzTWNZV243X0NuVW9qSk9YTy04RGRhMUtYNi03cHNKeFhubC1uSHlPQ08xd25WaG5mc1FVV0RzOS1MMUxPVFdvaXlkZDFyZDBGcWFMcXZUNzdPMC1XNUtuLVZBV3ZjQzItSVRRMFR3TEY1SEI4QU5kWm8xQnRCWmF3?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-12T16:49:09+00:00", "published_display": "12 Jul 2026 16:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson (JNJ) Faces Upheld $45 Million Talc Verdict In Illinois", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-10T23:50:14+00:00", "published_display": "10 Jul 2026 23:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bank of America Issues Positive Forecast for Johnson & Johnson (NYSE:JNJ) Stock Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxQT21Ra1Q2SDdQZkNyN0lYMFpOajJDS1pvekxCTDJCdHh5Q3N5M1NVcExBQmdubDB3OTRWN3d1clJoVHFPQVFxclBDdHVhUDlQR1hSc2tWNHBiUl9pQ1ZSSmo4OTMwRlJ3bXNSbkoxR2QxZzNUOFlVazFtNnFpVkJ2SDZxbjlSZmlBYVFCcDNMc0ROclNqaWlnZUdUc2ZSenhOV18wTTBPN3FZdTB4Wl81dVRFTXpPUTVlNzEzRklXWkdzLVlwaUJKeWpIYmExWjQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-10T18:16:06+00:00", "published_display": "10 Jul 2026 18:16", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson (JNJ) Highlights IMAAVY Data, Is The Stock Above Fair Value?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-08T08:38:50+00:00", "published_display": "08 Jul 2026 08:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson $JNJ Stock Holdings Increased by New York State Teachers Retirement System", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxNNVk2RzRVWUhpUndIOFgzbnBoRjBPdnR4QksydDE5SXR4SkNMY1QyZmhWVFRjdmszQmI5V3ktMnZaODU2VUdzbmNyeERxM1g2VjFJbXE5MzZkTWdSVHRtemlCbkFaWmdVXzVPLUhSNGRUMFdnbDRuV0gxbkl4VUgyVkZWWENraW8za2VsZ0d5ZXhqQ3d2X0VraEdYMjhWNjFGa0RMT2JpSk9iWHEtZFRZbE5qRnhzRmRtd25RX09zVXNOWW9laEZhaU95TmNCNDNaeENDVHU2TlVLMTZFZ2xYS1Jlay0?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson (JNJ) Stock Looks Undervalued On Cash Flow While Earnings Look Fair", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-05T07:57:22+00:00", "published_display": "05 Jul 2026 07:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Johnson & Johnson (JNJ) Using IMAAVY\u2019s gMG and Pregnancy Data to Deepen Its Immunology Moat?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-03T00:21:16+00:00", "published_display": "03 Jul 2026 00:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson (JNJ) Stock After 73% One-Year Rally Is There Value Left", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNMXRiN0hmU0xUMUpjVDVzTXAtZ2xOZHZpdENrWW9FMFhyMUJHVmVkY1l5V05WY0dqX1E2UnRhTUxNR0FfZExuNGNJdUlQNDNlcE5pQUtQNVVsN0NiazhJbXRzdXMxT2VPcWpEOGVBY213V2xEZHNfckpZTkpLWDZhNGJiZ3Nfc0pCbzIzcFVzVzBZdXFWNXZxUw?oc=5", "source_name": "Market source", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson (JNJ) Surges 4.0%: Is This an Indication of Further Gains?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPaGw0RkxkMWNTaHJUdHBjZjFRTDQtdXZma3piLWxRLU1rSHI5dncyNUF2NUtYRGx5NG9BeVhwX2RmYXpkX2FjbUw3WXRSWkpGSVp6dGEta2M1WnFnZURZX0hoUGo1SnN2T0xCOWlBUV9jQW1hOXF1MzU3dzloSVhkVHRZSmZWUjlabldSRmZFRmVwci0zTE5CVA?oc=5", "source_name": "Market source", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "122,800 Shares in Johnson & Johnson $JNJ Acquired by Louisiana State Employees Retirement System", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxPdko4dGw5djBtZWxNenhOV3VWUWV5b29XM0NzWHZjQURMT19JcEhrN1FWYlk4aWtFSmI3S2gxNTN0TFEzOHFUS1h0OElsZFhnYVlKZ19IRGw1NG1BZVVuYmxxcWJQMlE1WS1aY2s2Rzd0dl8zWHhWZEJseDJwZDRNdjFPUFBEQ25OYjVBUVVmVGN3UFNZNlR2ZUZnM0oxQWxQeXVnVVlicV9hNWVEVXp6d1M2b2M2ZHhYd0RGdVFIS3VJSGZkOGMxZXltNjVVaTY3OXBTYnFYX19wcTdKdkpnTHpOazlKYUZT?oc=5", "source_name": "MarketBeat", "published_at": "2026-06-28T08:51:35+00:00", "published_display": "28 Jun 2026 08:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Johnson & Johnson (JNJ) Is Using U.S. Manufacturing Investment to Strengthen Its Vision Business", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxOejcyV2pfSnUtb2wyQ1VvQWZrdzhmc2VubDVaSU5KaEQtbGVTOG93a0lVUkQyS1JKZHZzM01ISXpLQS1DNXNrUGhmbUhwQkVPazZOYzhoY01PM1Rfek9fX3U4cGpqVy1KTTFyZTVmQVZLVEVURHdVWnVQNkV2QkI2b2hJYm9jY2ptaG1oTjBSQWZDdw?oc=5", "source_name": "Market source", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson's US$1bn Investment for Vision & Eye Care", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxQV2ZMcEhSQW9uakJIRVRpN1Vmck5NSm1QOU8xNDNjcWd5VkN3VHFNT2g3NzNNZVlGbUg4OGlDSkNDQm1WMmVCc3RndGtXZ3lycFJMV0U3ODBscXc2NjhQc3hpNlhWV01wamRsaklUeHVLVlFrcmpQLUVoVEhxY0g5MjVtS3FkbzZteHJ3R3lSTTlJd2pD?oc=5", "source_name": "Healthcare Digital", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson to Invest Over $1 Billion in Florida Contact Lens Manufacturing Facility", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxPWG9YV2ZuRmJqdjlKMlMxaVdwcGNERXdNM1h6WEJJTmpNNG1GR0pvV3MyTkliLVdIT2V4Z1VWb2Zzc3E1NEpPbkNHNDVVNnM4Z1FfVzBPWW5nMFVSZV8yZ2x0UktIVWtUUmRLU3hqNHZrVWtfNmFhQTFFZFRabTFJcnl1V3R5WXRsdkdDWmpXdXlUeEt4?oc=5", "source_name": "Market source", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson Invests more than $1 Billion to Strengthen U.S. Vision Manufacturing in Jacksonville, Florida", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxNRkJWRlgweUJsTXJlVnRCeVpzX1o4eWZIUlo2WjRMRUNxVk5yNHc5enZtRUppUmlJM19CM0xxSjVyZDktWldtM3ZlOHp0Z2V1elNfalZIS0tVRDRydGlqSTFSY3NHbF9WRkE0b1JDZldVOUhUV25hX2hCNGZsZlVPRUY2b3VzN2k5bGp1Rm9vbjJob1hfT2RHX2NVQXBjQWJFTHA0SE54T25aMnNVWDMzdkhWLVN3cEVjR01hb3ZCbWxPdVVoTnhyeld1SDRfUDY4RExVS0gwcl9WbFI1VXB6M1RUUTgxUERFQkE?oc=5", "source_name": "Johnson & Johnson", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jim Cramer Says He Likes Drug Stocks Here As He Discusses Johnson & Johnson", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQUUotS2JraFhGNmxCNzVlSTZ1TUVYTWVPX0Rpb1ZKRUozMUNQR2g4dkJQY21nWGVsbDY4V2R4S0hhNTdQRkZUZ1Zqb3RDclJzcjlzcG5HOFhqN05DbWpZN1ZBci1nWFJoMHFGZzRUZWZKa1c3QXJZUmJnWlJOa2R6T0NiTDhsQU51MTFEV2l2RHg3T0l6cEZhczlDcw?oc=5", "source_name": "Market source", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson MedTech Chief Just Revealed What\u2019s Coming for the EP Market. Here\u2019s What Investors Should Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNbHB2endjWEtuTEFOeW55SS1zSjVxMmxseTl0bzRJNi1aVGZWWXlGQ0kybVBsb2NYeW4za0o5M29hR0lsNUNLcTFTdDltME9EVVRCUGkyVWRzTzdES2MyVm1lUGpWT3R2Z2hNeWtKQ01wUDlXR2owRmVsYVRhV3VZYUNPYkk0TGFXTXREVUZZZnlPSTdIVFQzUVJJRmpyQ1RDWHc4QmZfMDFSMWZOaUNMN3daY2p6OWNKNnJTOHN4MUdtZVp6UW1PaUxoVURtZw?oc=5", "source_name": "TIKR.com", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson & Johnson: Why This Popular Core Stock Is a Sell", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE94Rkg2UTB1bHFKMFRZRWJQX21MOEozTnBXVGpUR2tzaWJGbEliY2FVSkw1RVRXUHYzXzd4bGpnSzNNWncySzlfSFZJRXNxbHpBdE9ucGtwaFVVVWFuZXVNZ2RVZFNYaDBvVENhWVRQRUxCRWxVcFo2N21B?oc=5", "source_name": "Morningstar", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Reassess Johnson & Johnson (JNJ) After Recent Litigation Headlines?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPQW0tcm4yVklUOUl5TWtTeXdqQTFpdXpZdHVNX19QMnhfd3lXVGZyVFRTWmxXZHg3M0NzSVBpenBiS2U2bTNBUzhTYXRTaHNhWEl3eGk0TDh0bEVscWlETjZhaHBOMjdKbFZFWEVmcVZMN0RvNDBLMFAySU1BZ0FDT0ZDMVdhWFFOUXpuLWFBMWl2Tkc2S3lydEhzWmp4enM?oc=5", "source_name": "Market source", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 117, "total_relevant": 55, "sentiment_summary": {"positive": 21, "negative": 4, "neutral": 30, "score": 55, "total": 55, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 16.3, "count": 29}, {"event": "earnings", "label": "Earnings", "weight": 9.65, "count": 15}, {"event": "analyst", "label": "Analyst action", "weight": 4.4, "count": 8}, {"event": "guidance", "label": "Guidance", "weight": 1.45, "count": 2}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.55, "count": 1}], "positive_events": 21, "negative_events": 4}, "market_context": {"has_market_context": true, "latest_close": 256.98, "latest_week": "2026-07-10", "one_week_move": -2.3, "four_week_move": 6.7, "twelve_week_move": 10.4, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.300551, "market_dynamics_buy_signal": false, "relative_strength": 10.316716, "fair_value_gap": 52.4, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 51.0345, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-2.3% over one week, +6.7% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 63, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "MarketBeat", "count": 12}, {"label": "MT Newswires", "count": 8}, {"label": "Market source", "count": 8}, {"label": "simplywall.st", "count": 5}, {"label": "Morningstar", "count": 2}, {"label": "Barron's", "count": 2}, {"label": "BioSpace", "count": 2}, {"label": "Fierce Biotech", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 55}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 29}, {"label": "Earnings", "count": 15}, {"label": "Analyst action", "count": 8}, {"label": "Guidance", "count": 2}, {"label": "Macro sensitivity", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "55", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "6", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-2.3% over one week, +6.7% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Goldman Sachs Adjusts Price Target on Johnson & Johnson to $282 From $275, Maintains Buy Rating"}], "updated_at": "2026-07-16T11:43:21.716061+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}